Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapy.

• To evaluate the association between the interval from breast-conserving surgery (BCS) to radiotherapy (RT) and the clinical outcome among patients treated with adjuvant endocrine therapy.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Age Factors

Antineoplastic Agents

Hormonal

therapeutic use

Antineoplastic Combined Chemotherapy Protocols

administration & dosage

therapeutic use

Breast Neoplasms

chemistry

drug therapy

mortality

prevention & control

radiotherapy

surgery

Chemotherapy

Adjuvant

methods

Combined Modality Therapy

methods

Cyclophosphamide

administration & dosage

Disease-Free Survival

Female

Fluorouracil

administration & dosage

Humans

Mastectomy

Segmental

Menopause

Methotrexate

administration & dosage

Middle Aged

Neoplasm Recurrence

Local

prevention & control

Proportional Hazards Models

Receptors

Estrogen

analysis

Regression Analysis

Tamoxifen

therapeutic use

Time Factors

Publication and Content Type

ref (subject category)

art (subject category)